Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G WOODRUFF

Showing results (341-350 of 384) with videos related to

Pageof 39
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
JAMA|August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryWilliam McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society|September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS CohortDaniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary diseaseLisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Dysanapsis Genetic Risk Predicts Lung Function Across the LifespanCatherine L Debban, Amirthagowri Ambalavanan, Auyon Ghosh, et al.
Scientific Reports|May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPDKatarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
Pageof 39

Showing results (341-350 of 384) with videos related to

Sort By:
Pageof 39
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
JAMA|August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryWilliam McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society|September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS CohortDaniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary diseaseLisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Dysanapsis Genetic Risk Predicts Lung Function Across the LifespanCatherine L Debban, Amirthagowri Ambalavanan, Auyon Ghosh, et al.
Scientific Reports|May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPDKatarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
Pageof 39